Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 1
2016 1
2017 1
2018 5
2019 4
2020 1
2022 1
2024 1
2025 4
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
The prognostic and therapeutic potentials of CTLA-4 in hematological malignancies.
Sadeghi M, Khodakarami A, Ahmadi A, Fathi M, Gholizadeh Navashenaq J, Mohammadi H, Yousefi M, Hojjat-Farsangi M, Movasaghpour Akbari AA, Jadidi-Niaragh F. Sadeghi M, et al. Expert Opin Ther Targets. 2022 Dec;26(12):1057-1071. doi: 10.1080/14728222.2022.2170781. Epub 2023 Jan 24. Expert Opin Ther Targets. 2022. PMID: 36683579 Review.
Global prevalence of Fusobacterium nucleatum and Bacteroides fragilis in patients with colorectal cancer: an overview of case reports/case series and meta-analysis of prevalence studies.
Sameni F, Elkhichi PA, Dadashi A, Sadeghi M, Goudarzi M, Eshkalak MP, Dadashi M. Sameni F, et al. Among authors: sadeghi m. BMC Gastroenterol. 2025 Feb 10;25(1):71. doi: 10.1186/s12876-025-03664-x. BMC Gastroenterol. 2025. PMID: 39930345 Free PMC article.
The presence of Fusobacterium nucleatum (F. nucleatum) and Bacteroides fragilis (B. fragilis) in the gut is associated with the development of CRC. In this study, the prevalence of F. nucleatum and B. fragilis among CRC patients has been assessed worldwide through a …
The presence of Fusobacterium nucleatum (F. nucleatum) and Bacteroides fragilis (B. fragilis) in the gut is associated with the devel …
Assessing Heterogeneity Effects on Points A, B, and Organs at Risk Doses in High-dose-Rate Brachytherapy for Cervical Cancer - A Comparison of (192)Ir and (60)Co Sources Using Monte Carlo N-Particle 5.
Sadeghi MH, Sina S, Meigooni AS. Sadeghi MH, et al. J Med Phys. 2024 Apr-Jun;49(2):294-303. doi: 10.4103/jmp.jmp_162_23. Epub 2024 Jun 25. J Med Phys. 2024. PMID: 39131438 Free PMC article.
However, when comparing the absorbed doses at critical points such as Point A right, Point A left, Point B right, Point B left, bladder International Commission on Radiation Units and Measurement (ICRU) point, and recto-vaginal ICRU point, the study revealed signifi …
However, when comparing the absorbed doses at critical points such as Point A right, Point A left, Point B right, Point B left …
MicroRNA Signatures Predict Brain Amyloidosis and Neurodegeneration in Alzheimer's Disease: Insights from [18F] AV45 and FDG PET Imaging.
Saberian P, Darvishi A, Khezragha D, Forouzandegan M, Farhadieh ME, Taghizadeh Khorshidi S, Hatami Nejad M, Sedighi S, Barati R, Safavi SAR, Sadeghi M, Gulisashvili D, Mayeli M, Shakeri S. Saberian P, et al. Among authors: sadeghi m. Brain Behav. 2025 May;15(5):e70572. doi: 10.1002/brb3.70572. Brain Behav. 2025. PMID: 40418688 Free PMC article.
FINDINGS: The study found a significant positive correlation between CSF levels of miR-210-3p and Abeta accumulations in the brain (B = 4.69). Conversely, miR-223-3p levels were significantly lower in APOE-epsilon4 carriers. ...
FINDINGS: The study found a significant positive correlation between CSF levels of miR-210-3p and Abeta accumulations in the brain (B …
Comparison of the effect of corticosteroid therapy and decongestant on reducing rhinoplasty edema.
Saedi B, Sadeghi M, Fekri K. Saedi B, et al. Among authors: sadeghi m. Am J Rhinol Allergy. 2011 Jul-Aug;25(4):e141-4. doi: 10.2500/ajra.2011.25.3601. Am J Rhinol Allergy. 2011. PMID: 21819749 Clinical Trial.
Group A received 8 mg of i.v. dexamethasone preoperatively and again after 24 and 48 hours after surgery, group B received three pseudoephedrine tablets (60 mg) per day for 1 week, and group C received three pseudoephedrine tablets (60 mg) per day for 2 weeks. ...
Group A received 8 mg of i.v. dexamethasone preoperatively and again after 24 and 48 hours after surgery, group B received three pseu …
19 results